DE69813935D1 - Verwendung von Retinoiden zur Induzierung von Hautpigmentierung - Google Patents
Verwendung von Retinoiden zur Induzierung von HautpigmentierungInfo
- Publication number
- DE69813935D1 DE69813935D1 DE69813935T DE69813935T DE69813935D1 DE 69813935 D1 DE69813935 D1 DE 69813935D1 DE 69813935 T DE69813935 T DE 69813935T DE 69813935 T DE69813935 T DE 69813935T DE 69813935 D1 DE69813935 D1 DE 69813935D1
- Authority
- DE
- Germany
- Prior art keywords
- retinoids
- skin pigmentation
- induce skin
- induce
- pigmentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000012641 Pigmentation disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
- A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9701500A FR2759292B1 (fr) | 1997-02-10 | 1997-02-10 | Utilisation de retinoides en tant qu'agents induisant la pigmentation |
FR9701500 | 1997-02-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69813935D1 true DE69813935D1 (de) | 2003-06-05 |
DE69813935T2 DE69813935T2 (de) | 2004-03-11 |
Family
ID=9503524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69813935T Expired - Fee Related DE69813935T2 (de) | 1997-02-10 | 1998-02-05 | Verwendung von Retinoiden zur Induzierung von Hautpigmentierung |
Country Status (6)
Country | Link |
---|---|
US (1) | US5942531A (de) |
EP (1) | EP0862910B1 (de) |
JP (1) | JP2954146B2 (de) |
DE (1) | DE69813935T2 (de) |
ES (1) | ES2198662T3 (de) |
FR (1) | FR2759292B1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6267948B1 (en) * | 1998-04-06 | 2001-07-31 | Applied Genetics Incorporated Dermatics | Dermatological formulations and methods |
DE19839402A1 (de) * | 1998-08-29 | 2000-03-02 | Beiersdorf Ag | Retinoide enthaltende Hautpflegemittel |
FR2799645B1 (fr) * | 1999-10-13 | 2004-04-30 | Oreal | Utilisation de la dhea ou de ses precurseurs ou derives metaboliques comme depigmentant |
FR2800243B1 (fr) * | 1999-11-02 | 2002-01-18 | Royal Canin Sa | Composition alimentaire ou veterinaire pour carnivore domestique contenant de la tyrosine libre pour prevenir les anomalies de pigmentation du pelage |
FR2804323B1 (fr) * | 2000-01-31 | 2006-07-07 | Galderma Res & Dev | Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens |
US20010014442A1 (en) * | 2000-02-09 | 2001-08-16 | Morris James G. | Essential constituent and method of use for maintaining hair coloration or reversing hair discoloration |
FR2840531B1 (fr) * | 2002-06-11 | 2004-10-29 | Oreal | Composition cosmetique comprenant un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) pour lutter contre la canitie |
US7368131B2 (en) * | 2003-02-27 | 2008-05-06 | Supernatural Health, Inc. | Method and composition for treating hypopigmentation of the hair and skin |
BRPI0517500B8 (pt) * | 2004-12-23 | 2021-05-25 | Galderma Res & Dev | composto, uso de uma composição, composição farmacêutica, composição cosmética, usos não-terapêuticos de uma composição cosmética e processo cosmético para melhorar a aparência da pele |
KR100798853B1 (ko) | 2005-02-15 | 2008-01-28 | (주)한국스티펠 | 레티노이드를 유효성분으로 하는 백반증 예방 및 치료용 약학적 조성물 |
DE102005056538A1 (de) * | 2005-11-28 | 2007-05-31 | Merz Pharma Gmbh & Co. Kgaa | Zusammensetzungen, enthaltend Proteine zum Transfer / Recycling strukturell veränderter Lipide aus Biomembranen, sowie deren Anwendungen |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
BR112014012444B1 (pt) | 2011-11-23 | 2021-12-14 | Therapeuticsmd, Inc | Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) * | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
KR102335160B1 (ko) * | 2013-10-22 | 2021-12-03 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 질내 삽입형 에스트라다이올 약제학적 조성물 및 방법 |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
MX2016013693A (es) | 2014-07-29 | 2017-10-31 | Therapeuticsmd Inc | Crema transdermica. |
CN111542312A (zh) * | 2017-07-28 | 2020-08-14 | 老龄化控制中心股份公司 | 预防和逆转衰老方面的组合物和方法 |
KR102635194B1 (ko) * | 2018-05-14 | 2024-02-13 | (주)아모레퍼시픽 | 다이아릴 유도체 화합물 및 그를 포함하는 피부 미백용 조성물 |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
WO2023064500A1 (en) * | 2021-10-13 | 2023-04-20 | Carnegie Mellon University | Multidimensional 3d graphene-based high-performance catalysts |
EP4292581A1 (de) | 2022-06-16 | 2023-12-20 | Bella Aurora Labs, S.A. | Haarfärbezusammensetzung |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU85849A1 (fr) * | 1985-04-11 | 1986-11-05 | Cird | Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques |
FR2663850B1 (fr) * | 1990-07-02 | 1994-01-14 | Gird Galderma | Composition pharmaceutique ou cosmetique contenant en association un retinouide et un sterol. |
MX9201084A (es) * | 1991-04-15 | 1992-12-21 | Bristol Myers Squibb Co | Hiper pigmentacion de la piel |
US5266307A (en) * | 1992-03-31 | 1993-11-30 | The Regents Of The University Of Michigan | Retinoic acid as a skin tanning agent in persons of light skin color |
JPH07118134A (ja) * | 1992-04-17 | 1995-05-09 | Koichi Shudo | 皮膚外用剤 |
GB9217444D0 (en) * | 1992-08-17 | 1992-09-30 | Unilever Plc | Compounds compositions and methods for producing pigmentation in hair or skin |
FR2733684B1 (fr) * | 1995-05-03 | 1997-05-30 | Cird Galderma | Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique |
CZ3499A3 (cs) * | 1996-07-08 | 1999-11-17 | Galderma Research & Development, S. N. C. | Adamantylová sloučenina, její použití a farmaceutický prostředek ji obsahující |
-
1997
- 1997-02-10 FR FR9701500A patent/FR2759292B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-05 DE DE69813935T patent/DE69813935T2/de not_active Expired - Fee Related
- 1998-02-05 EP EP98400256A patent/EP0862910B1/de not_active Expired - Lifetime
- 1998-02-05 ES ES98400256T patent/ES2198662T3/es not_active Expired - Lifetime
- 1998-02-09 JP JP10065994A patent/JP2954146B2/ja not_active Expired - Fee Related
- 1998-02-10 US US09/021,396 patent/US5942531A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0862910B1 (de) | 2003-05-02 |
EP0862910A3 (de) | 1998-10-28 |
JP2954146B2 (ja) | 1999-09-27 |
FR2759292B1 (fr) | 2000-08-11 |
FR2759292A1 (fr) | 1998-08-14 |
DE69813935T2 (de) | 2004-03-11 |
JPH10251116A (ja) | 1998-09-22 |
EP0862910A2 (de) | 1998-09-09 |
US5942531A (en) | 1999-08-24 |
ES2198662T3 (es) | 2004-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69813935D1 (de) | Verwendung von Retinoiden zur Induzierung von Hautpigmentierung | |
ID22061A (id) | Metoda perawatan pigmentasi kulit | |
ID28111A (id) | Metoda untuk meningkatkan kesehatan kulit | |
DE69827132D1 (de) | Anordnung zur anwendung von fibrin-kleber | |
DE69838338D1 (de) | Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen | |
DE69534734D1 (de) | Verwendung von astaxanthin zur verzögerung und verbesserung der augenschädigung | |
DE69600012D1 (de) | Verwendung von Salicylsäure-Derivativen zur Hautbleichung | |
DE69622154D1 (de) | Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses | |
ID21761A (id) | Komposisi perawatan kulit yang mengandung asam dan retinoid | |
DE69635933D1 (de) | Elektrochirurgische Entfernung von Geweben | |
ATE288748T1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
ID17437A (id) | Metoda dan komposisi untuk membuat kulit terang | |
DE69834560D1 (de) | Verwendung von lactobacillus zur verminderung des fibrinogengehalts im blut | |
ATE319504T1 (de) | Verwendung von nanodispersionen in kosmetischen endformulierungen | |
ID26999A (id) | Komposisi perawatan kulit | |
DE69807721T2 (de) | Verwendungen von moleküle zur kontrolle der eisbildung | |
DE69406302T2 (de) | Verwendung von östriolmessungen zur uberwachung tokolytischer therapie | |
DE69807454T2 (de) | Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden | |
DE60015516D1 (de) | Verwendung von makroliden zur behandlung von trockenen augen | |
ATE218862T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
ATE288207T1 (de) | Verwendung von 1-nonen-3-one als aromastoff | |
ATE217518T1 (de) | Verwendung mindestens eines in 6-stellung substituierten pyrimidin-3-oxids zur stimulierung von tyrosinase | |
ID27688A (id) | Metoda pembuatan kulit imitasi | |
DE69600118D1 (de) | Verwendung der Benzosäurederivate zur Stimulierung die Erneuerung der Epidermis und zur Behandlung der Haut | |
DE69719589T2 (de) | Retinoide enthaltende Hautpflegepräparate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |